Skip to Content

Rifaximin

In some countries, this medicine may only be approved for veterinary use.

In the US, Rifaximin (rifaximin systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Crohn's Disease, Diarrhea, Hepatic Encephalopathy, Irritable Bowel Syndrome and Traveler's Diarrhea.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A07AA11,D06AX11

CAS registry number (Chemical Abstracts Service)

0080621-81-4

Chemical Formula

C43-H51-N3-O11

Molecular Weight

786

Therapeutic Category

Antibacterial

Chemical Name

(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,6,21,23,25-Pentahydroxy-27-metoxy-2,4,11,16,20,22,24,26-octametyl-2,7-(epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione, 25-acetate (WHO)

Foreign Names

  • Rifaximinum (Latin)
  • Rifaximin (German)
  • Rifaximine (French)
  • Rifaximina (Spanish)

Generic Names

  • Rifaximin (OS: USAN, BAN, JAN)
  • Rifaximina (OS: DCIT)
  • L 105 (IS)
  • Rifaxidine (IS)
  • Rifaximin (PH: BP 2018, Ph. Eur. 9)
  • Rifaximine (PH: Ph. Eur. 9)
  • Rifaximinum (PH: Ph. Eur. 9)

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.